WebMar 31, 2024 · Gain Therapeutics Stock Down 2.3 % Shares of Gain Therapeutics stock opened at $4.71 on Thursday. The company has a debt-to-equity ratio of 0.03, a quick ratio of 5.11 and a current ratio of 5.11. WebMar 12, 2024 · Buy or sell stock? Will GANX stock price go up? What are analysts’ forecasts for GANX stock? Forecst.com predicts future values using technical analysis of a large …
Gain Therapeutics Inc Stock Forecast, Predictions & Price Target
WebMar 21, 2024 · GATX one year forecast. GATX stock monthly and weekly forecasts. Skip to content. FORECST.COM 2024 – 2026 Stock Market Forecast GATX stock forecast for 2024 – 2027. Last updated: March 21, 2024. Are you interested in GATX Corporation stocks prediction? ... GANX Stock Forecast; GAN Stock Forecast; WebApr 5, 2024 · GANX Stock Overview. Gain Therapeutics, Inc., a biotechnology company, researches and develops novel therapies to treat diseases caused by protein misfolding in Switzerland and Spain. ... Consensus forecasts updated May 23. Gain Therapeutics, Inc., Annual General Meeting, Jun 16, 2024 May 14. Price target decreased to US$22.00 Apr … chinese work visa types
Achieve Life Sciences Stock Forecast: down to 3.741 USD? - ACHV Stock …
WebApr 11, 2024 · NASDAQ:GAN GAN - GAN Stock Forecast, Price & News $1.33 +0.04 (+3.10%) (As of 04/11/2024 10:20 AM ET) Compare Today's Range $1.29 $1.34 50-Day … WebMar 31, 2024 · Stock Price Forecast. According to 10 stock analysts, the average 12-month stock price forecast for GANX stock is $ 8.67 , which predicts an increase of 137.86%. The lowest target is $ 4.04 and the highest is $ 10.5. On average, analysts rate GANX stock as a buy. WebUpgrade to Premium to see how . GANX scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks. Try It for Just $1. ... Gain Therapeutics 's market cap is calculated by multiplying GANX's current stock price of $3.67 by GANX's total outstanding shares of 11,883,368. grange infant school burton on trent